Adjutec Pharma AS
- Address
- Ullernchausseen 64
Sponsor Overview
Specializations
Immunological and Allergic Disease Research
Adjutec Pharma AS demonstrates a focused commitment to advancing therapeutic solutions in the field of immunological disorders and allergic conditions. The company's research portfolio emphasizes novel approaches to modulating immune responses and addressing hypersensitivity reactions that affect patient quality of life.
- Allergic Rhinitis and Respiratory Allergies
- Immunomodulatory Therapies
- Allergic Sensitization Mechanisms
The sponsor's therapeutic development strategy centers on creating innovative interventions for patients suffering from allergic rhinitis and related upper respiratory allergic conditions. This research addresses a significant unmet medical need in populations experiencing seasonal and perennial allergic manifestations, with particular attention to improving symptom control and long-term disease management through immune system modulation.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, and Pharmacokinetics of APC148 in a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Healthy Adults |  Sweden | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
Partnered Research Centres
1 centre- Address
- Dag Hammarskjolds Vag 10b, Uppsala Domkyrkofors., 752 37 Uppsala
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Adjutec Pharma AS.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.